Bony morbidity in children treated for acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 19, Issue 12, 2001, Pages 3066-3072

  Strauss, A J ^a   Su, J T ^a   Kimball Dalton, V M ^a   Gelber, R D ^a   Sallan, S E ^a   Silverman, L B ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; BONE NECROSIS; CANCER INCIDENCE; CANCER SURVIVAL; CHILD; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; FOLLOW UP; FRACTURE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE;

EID: 0035876443     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.12.3066     Document Type: Article

References (38)

1. Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01
2. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90
3. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia
4. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia
5. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia
6. Relative osteopenia after treatment for acute lymphoblastic leukemia
7. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood
8. Reduced bone density at completion of chemotherapy for a malignancy
9. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia
10. Osteonecrosis: Current perspectives on pathogenesis and treatment
11. Avascular femoral head necrosis in pediatric cancer patients
12. Avascular necrosis of bone following an intensified chemotherapy regimen including high dose steroids
13. Avascular necrosis in children with acute lymphoblastic leukemia
14. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: A report from the Children's Cancer Group
15. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: A prospective MRI study
16. Differences in cerebrospinal fluid penetration of corticosteroids: Possible relationship to the prevention of meningeal leukemia
17. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia
18. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia
19. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia
20. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)
21. Adrenocorticotropic hormone; adrenocortical steroids and their analogs; inhibitors of adrenocortical steroid biosynthesis
22. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators
23. A class of K-sample tests for comparing the cumulative incidence of a competing risk
24. Nonparametric estimation from incomplete observations
25. Fracture patterns in children: Analysis of 8,682 fractures with special reference to incidence, etiology and secular changes in a Swedish urban population 1950-1979
26. Fracture patterns in Nottingham children
27. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia
28. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone
29. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group
30. Dexamethasone decreases central nervous system relapse and improves event-free survival in lower risk acute lymphoblastic leukemia
31. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia
32. Osteoporosis due to cancer treatment: Pathogenesis and management
33. Impact of age and cranial irradiation on radiographic skeletal pathology in children with acute lymphoblastic leukemia
34. Limb fracture pattern in different pediatric age groups: A study of 3,350 children
35. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
36. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis